Psychosis Mental and Behavioural Disorders
Conditions
Interventions
Video Interaction Guidance (VIG):
VIG is a brief, strengths-based video feedback intervention that uses videotaped interactions of the parent and child to enhance parental responsiveness to the child’
Sponsors
Oxford Health NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 20/07/2026: Parent: 1. Patient of mental health services (at the time of referral to the trial) 2. A clinical diagnosis of schizophrenia spectrum psychosis (non-affective psychosis) (ICD 10 codes F20–29) or bipolar disorder (F31) with psychotic symptoms (affective psychosis) 3. Caregiving responsibilities for child aged 2-48 months 4. Able to speak English or, if not, willing to involve an interpreter to engage in the trial 5. Willing and able to give informed consent Child: 1. Aged between 2 and 48 months at the time of the parent's referral to the trial 2. In regular contact with the participating parent 3. The child’s parent or legal guardian has provided informed consent for their participation in the study procedures Parent qualitative study: 1. Consent to have interviews audio recorded 2. Participation in the study (n = 5); randomised to the intervention arm and having received at least one cycle of VIG (n = 10) Clinician qualitative study: 1. Consent to have interviews audio recorded 2. Experience of either delivering VIG to study participants, or referring a parent to the study, or working with parents with psychosis and young children in the recruiting Trusts Previous inclusion criteria: Parent: 1. Patient of mental health services (at the time of referral to the trial) 2. A clinical diagnosis of schizophrenia spectrum psychosis (non-affective psychosis) (ICD 10 codes F20–29) or bipolar disorder (F31) with psychotic symptoms (affective psychosis) 3. Caregiving responsibilities for child aged 2-36 months 4. Able to speak English or, if not, willing to involve an interpreter to engage in the trial 5. Willing and able to give informed consent Child: 1. Aged between 2 and 36 months at the time of the parent's referral to the trial 2. In regular contact with the participating parent 3. The child’s parent or legal guardian has provided informed consent for their participation in the study procedures Parent qualitative study: 1. Consent to have interviews audio recorded 2. Participation in the study (n = 5); randomised to the intervention arm and having received at least one cycle of VIG (n = 10) Clinician qualitative study: 1. Consent to have interviews audio recorded 2. Experience of either delivering VIG to study participants, or referring a parent to the study, or working with parents with psychosis and young children in the recruiting Trusts
Exclusion criteria
Exclusion criteria: Parent: 1. A co-parent is participating in the trial 2. The parent is engaged in another parenting intervention 3. The eligible parent has psychotic symptoms or cognitive difficulties or substance misuse problems that are sufficiently severe to prevent them engaging with the intervention or completing study measures 4. Contact between the parent and child is not permitted by social services 5. Any other factor (for example, current active suicidal plans) which, in the judgement of the investigator, would preclude the participant from providing informed consent or from safely engaging with the trial procedures. Child: 1. Contact with the participating parent is prohibited by social services or a court order 2. The child is already enrolled in another parenting study 3. A sibling is participating in the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measures relate to the feasibility and acceptability of the trial procedures and intervention. The primary efficacy outcome is parent-child interaction (parental responsiveness), assessed using video clips coded using the Emotional Availability (EA) Scales by trained independent raters, at baseline, 16 weeks, and 28 weeks. The video clips of parents and infants up to 15 months will also be rated on the CARE-index by a trained independent rater at baseline, 16 weeks and 28 weeks. Feasibility parameters measured at baseline, 16 and 28 weeks: 1. Number of patients eligible, approached, and consented to participate 2. Number recruited, recruitment rate, and proportion of mothers and fathers recruited 3. Range and average number of sessions attended 4. Proportion of participants completing all planned intervention sessions 5. Number of participants who withdraw from the study and when they withdraw 6. Any adverse effects of participating in the study 7. Acceptability of the intervention, assessed qualitatively post-intervention 8. Reasons for participants not completing the intervention as planned, assessed qualitatively post-intervention 9. Number of participants who complete the outcome measures at each time point and the completeness of their data, and acceptability of the measures assessed qualitatively post-intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Parent-child interaction is assessed using video clips coded on the Emotional Availability (EA) Scales by trained independent raters at baseline, 16 weeks, and 28 weeks. Video clips of parents and infants up to 15 months are also coded by independent raters on the CARE-index at baseline, 16 weeks, and 28 weeks. 2. Parental mental health is measured using the Depression, Anxiety and Stress Scale at baseline, 16 and 28 weeks 3. Parenting stress is measured using the Parental Stress Scale at baseline, 16 and 28 weeks 4. Social and emotional wellbeing of children is assessed using the parent-reported Ages and Stages Questionnaire: Social and Emotional at baseline, 16 and 28 weeks 5. Health and social care use by the parent and child is assessed using the Client Service Receipt Inventory (CSRI), adapted for this patient group, at baseline and 28 weeks 6. Parental quality of life is measured using the EQ-5D-5L at baseline, 16 and 28 weeks 7. NHS treatments and service use are extracted from the electronic patient record at baseline and 28 weeks | — |
Countries
England, United Kingdom
Outcome results
None listed